Top

Published in:

01-12-2018 | Case Report - Pituitaries

Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin’s lymphoma and responding to doxorubicin treatment: case report and review of the literature

Authors: Gregory P. Lekovic, Asheesh Batra, Zachary R. Barnard, Eric P. Wilkinson, Richard Balena, Sheri Palejwala, Garni Barkhoudarian

Published in: Acta Neurochirurgica | Issue 12/2018

Abstract

We present a case report of a patient who presented with nausea and vomiting, as well as acromegalic features. Following testing, a pituitary adenoma and mediastinal non-Hodgkin’s lymphoma were diagnosed. Following two cycles of R-CHOP chemotherapy, imaging showed significant decrease in size of the sellar tumor. Following resection of tumor, both frozen and permanent section revealed only necrotic material. Further research into the potential utility of doxorubicin for the treatment of recurrent or refractory pituitary adenomas may be warranted.

Attanasio R, Orlandi P, Dallabonzana D, Lodrini A, Ferrari M, Maccagnano E, Verde G, Cozzi R, Liuzzi A, Chiodini PG (1991) Doxorubicin for acromegaly: a case report. J Endocrinol Investig 14:493–497CrossRef

Aydogan BI, Unluturk U, Emral R, Gullu S (2017) Course of aggressive somatotroph, corticotroph and mammotroph tumors under temozolomide; report of three cases and review of the literature. Turk Neurosurg. https://doi.org/10.5137/1019-5149.JTN.20216-17.1

Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G (2001) Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779–2786. https://doi.org/10.1210/jcem.86.6.75564 CrossRefPubMed

Freda PU (2002) Somatostatin analogs in acromegaly. J Clin Enocrinol Metab 87:3013–3018. https://doi.org/10.1210/jcem.87.7.8665 CrossRef

Kasperlik-Zaluska AA, Wislawski J, Kaniewska J, Zborzil J, Frankiewicz E, Zgliczynski S (1987) Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol 116:347–349CrossRef

Lancranjan I, Bruns C, Grass P, Jaquet P, Jervell J, Kendall-Taylor P, Lamberts SW, Marbach P, Orskov H, Pagani G, Sheppard M, Simionescu L (1996) Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism 45:67–71CrossRef

Liu X, Ma S, Dai C, Cai F, Yao Y, Yang Y, Feng M, Deng K, Li G, Ma W, Xin B, Lian W, Xiang G, Zhang B, Wang R (2013) Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor alpha-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells. Endocrinology 154:1414–1423CrossRef

Ravindra VM, Raheja A, Corn H, Driscoll M, Welt C, Simmons DL, Couldwell WT (2017) Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report. J Neurosurg 126:1725–1730CrossRef

Roberts BK, Ouyang DL, Lad SP, Chang SD, GRt H, Adler JR Jr, Soltys SG, Gibbs IC, Remedios L, Katznelson L (2007) Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 10:19–25CrossRef

10.

Tritos NA, Biller BM (2017) Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly. Pituitary 20:129–135CrossRef

Title: Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin’s lymphoma and responding to doxorubicin treatment: case report and review of the literature
Authors: Gregory P. Lekovic
Asheesh Batra
Zachary R. Barnard
Eric P. Wilkinson
Richard Balena
Sheri Palejwala
Garni Barkhoudarian
Publication date: 01-12-2018
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 12/2018
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-018-3714-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin’s lymphoma and responding to doxorubicin treatment: case report and review of the literature

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2018

Spinal cord stimulation modulates descending pain inhibition and temporal summation of pricking pain in patients with neuropathic pain

A coil in the hair—a case report of percutaneous coil migration

External validation of cerebral aneurysm rupture probability model with data from two patient cohorts

Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report

Prior bariatric surgery lowers complication rates following spine surgery in obese patients

Reader comments to media reports on psychiatric neurosurgery: past history casts shadows on the future